Zaloguj się

Gotowe bibliografie tematyczne / Multipotency / Książki

Książki na temat „Multipotency”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Multipotency.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 21 najlepszych książek naukowych na temat „Multipotency”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Harrison, Andrew James. Evidence of multipotency in immortalised cells derived from bone marrow stroma. Manchester: University of Manchester, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Hoffman, Robert M., red. Multipotent Stem Cells of the Hair Follicle. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3786-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Bamba, Shigeki. Gut stem cells: Multipotent, clonogenic, and the origin of gastrointestinal cancer. New York: Nova Science Publishers, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Pearson, Mark Andrew. Investigation of molecular mechanisms involved in cytokine synergy in multipotent haemopoietic cells. Manchester: University of Manchester, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Reynolds, Brent A., i Loic P. Deleyrolle. Neural progenitor cells: Methods and protocols. New York: Humana Press, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Amit, M., i Joseph Itskovitz-Eldor. Atlas of human pluripotent stem cells: Derivation and culturing. New York: Humana Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Hoffman, Robert M. Multipotent Stem Cells of the Hair Follicle: Methods and Protocols. Springer New York, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Hoffman, Robert M. Multipotent Stem Cells of the Hair Follicle: Methods and Protocols. Springer New York, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Reynolds, Brent A., i Loic P. Deleyrolle. Neural Progenitor Cells: Methods and Protocols. Humana Press, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Deleyrolle, Loic P. Neural Progenitor Cells: Methods and Protocols. Springer, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Deleyrolle, Loic P. Neural Progenitor Cells: Methods and Protocols. Springer, 2022.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Fulcoli, F. Gabriella, i Antonio Baldini. Transcriptional regulation of early cardiovascular development. Redaktorzy José Maria Pérez-Pomares, Robert G. Kelly, Maurice van den Hoff, José Luis de la Pompa, David Sedmera, Cristina Basso i Deborah Henderson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198757269.003.0006.

Pełny tekst źródła

Streszczenie:

The two major cardiac cell lineages of the vertebrate heart, the first and second cardiac fields (FHF and SHF), have different developmental ontogeny and thus different transcription programs. Most remarkably, the fate of cardiac progenitors (CPs) of the FHF is restricted to cardiomyocyte differentiation. In contrast, SHF CPs, which are specified independently, are maintained in a multipotent state for a relatively longer developmental time and can differentiate into multiple cell types. The identity of the transcription factors and regulatory elements involved in progenitor cell programming and fate are only now beginning to emerge. Apparent inconsistencies between studies based on tissue culture and in vivo embryonic studies confirm that the ontogeny of cardiac progenitors is strongly driven or affected by regionalization, and thus by the signals that they receive in different regions. This chapter summarizes current knowledge about transcription factors and mechanisms driving CP ontogeny, with special focus on SHF development.

Style APA, Harvard, Vancouver, ISO itp.

13

Induced Pluripotent Stem Cells Springerbriefs in Stem Cells. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Itskovitz-Eldor, Joseph, i Michal Amit. Atlas of Human Pluripotent Stem Cells: Derivation and Culturing. Humana, 2016.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Itskovitz-Eldor, Joseph, i Michal Amit. Atlas of Human Pluripotent Stem Cells: Derivation and Culturing. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Mesenchymal Stem Cell Therapy Stem Cell Biology and Regenerative Medicine. Humana Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Tyndall, Alan, i Jacob M. van Laar. Stem cell therapies. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0085.

Pełny tekst źródła

Streszczenie:

Since the start of the international project in 1997, over 1500 patients have received a haematopoietic stem cell transplant (HSCT), mostly autologous, as treatment for a severe autoimmune disease, with overall 85% 5-year survival and 43% progression-free survival. Around 30% of patients in all disease subgroups had a complete response, often durable despite full immune reconstitution. In many cases, e.g. systemic sclerosis, morphological improvement such as reduction of skin collagen and normalization of microvasculature was documented, beyond any predicted known effects of intense immunosuppression alone. It is hoped that the results of the three running large prospective randomized controlled trials will allow modification of the protocols to reduce the high transplant-related mortality which relates to regimen intensity, age of patient, and comorbidity. Multipotent mesenchymal stromal cells (MSC) have been recently tested in various autoimmune diseases, exploiting their immune modulating properties and apparent low acute toxicity. MSC display immune privilege in that the patient requires no immunosuppression prior to allogeneic MSC infusion. Despite encouraging small phase I/II studies, no positive data from randomized prospective studies are as yet available in the peer-reviewed literature.

Style APA, Harvard, Vancouver, ISO itp.

18

Tyndall, Alan, i Jacob M. van Laar. Stem cell therapies. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0085_update_003.

Pełny tekst źródła

Streszczenie:

Since the start of the international project in 1997, over 2000 patients have received a haematopoietic stem cell transplant (HSCT), mostly autologous, as treatment for a severe autoimmune disease, with overall 85% 5-year survival and 43% progression-free survival. Around 30% of patients in all disease subgroups had a complete response, often durable despite full immune reconstitution. In many cases, e.g. systemic sclerosis, morphological improvement such as reduction of skin collagen and normalization of microvasculature was documented, beyond any predicted known effects of intense immunosuppression alone. It is hoped that the results of the three running large prospective randomized controlled trials will allow modification of the protocols to reduce the high transplant-related mortality which relates to regimen intensity, age of patient, and comorbidity. Multipotent mesenchymal stromal cells (MSC) have been recently tested in various autoimmune diseases, exploiting their immune modulating properties and apparent low acute toxicity. MSC display immune privilege in that the patient requires no immunosuppression prior to allogeneic MSC infusion. Despite encouraging many small phase I/II studies, only 2 prospective controlled trials which achieved their primary endpoints have been published.

Style APA, Harvard, Vancouver, ISO itp.

19

J, Prockop Darwin, Phinney Donald G i Bunnell Bruce A, red. Mesenchymal stem cells: Methods and protocols. Totowa, NJ: Humana Press, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Bunnell, Bruce A., Darwin J. Prockop i Donald G. Phinney. Mesenchymal Stem Cells: Methods and Protocols. Humana Press, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

(Editor), Darwin J. Prockop, Donald G. Phinney (Editor) i Bruce A. Bunnell (Editor), red. Mesenchymal Stem Cells: Methods and Protocols (Methods in Molecular Biology). Humana Press, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!